Your search for "press%20releases" return 9 results.
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
New Research Adds Support to Change Heartworm Protocol >
Phase 2 Study calls for fighting both the mosquito and the heartworm
Ceva Animal Health Receives Contract to Provide Avian Influenza Vaccine for USDA stockpile >
Ceva receives contract to produce avian influenza vaccine.
Craig Wallace named finalist for the EY Entrepreneur Of The Year® 2015 Award in the Central Midwest >
EY Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs.
Ceva in exclusive merger negotiations with Sogeval >
French veterinary pharmaceutical companies Ceva Santé Animale (Ceva), based in Libourne, and Sogeval (a subsidiary of Sofiprotéol), based in Laval have entered into exclusive merger negotiations.
Dr. Karen Padgett Named COO of Ceva's Companion Animal Group >
Appointment sets tone for continued growth & commitment to veterinary profession
Ceva Animal Health Supports AAFP Cat Friendly Practice Initiative >
Cosponsors program developed by AAFP
Ceva conducts Global Vector Vaccine Symposium >
Ceva, a global leader in vector vaccines technology, hosted over 280 participants from 41 countries at its first Vector Vaccine Symposium on October 06-08, 2010.